VHCP Management II

VHCP Management II as of Sept. 30, 2016

Portfolio Holdings for VHCP Management II

VHCP Management II holds 24 positions in its portfolio as reported in the September 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Avexis 21.9 $43M 1.0M 41.21
BioCryst Pharmaceuticals (BCRX) 12.9 $25M 5.7M 4.41
Edge Therapeutics 10.3 $20M 1.9M 10.41
Dbv Technologies 10.0 $19M 374k 52.04
Ascendis Pharma A S (ASND) 7.4 $15M 721k 20.10
Cytomx Therapeutics (CTMX) 4.7 $9.1M 578k 15.68
Audentes Therapeutics 3.7 $7.3M 459k 15.84
Heron Therapeutics (HRTX) 3.6 $7.0M 406k 17.23
Colucid Pharmaceuticals 3.1 $6.1M 159k 38.15
Axovant Sciences 3.1 $6.0M 430k 14.00
Regenxbio Inc equity us cm (RGNX) 2.4 $4.7M 333k 14.01
Alcobra 1.9 $3.8M 1.5M 2.47
Beigene (BGNE) 1.9 $3.7M 119k 30.81
Coherus Biosciences (CHRS) 1.8 $3.5M 130k 26.78
D Stemline Therapeutics 1.8 $3.4M 316k 10.83
Achillion Pharmaceuticals 1.8 $3.4M 420k 8.10
Akari Therapeutics 1.6 $3.1M 370k 8.51
ARCA biopharma 1.6 $3.1M 1.1M 2.83
Ocera Therapeutics 1.5 $2.9M 1.1M 2.64
Aeglea Biotherapeutics 1.1 $2.2M 350k 6.38
Lipocine 1.0 $1.9M 420k 4.46
Adverum Biotechnologies (ADVM) 0.6 $1.2M 280k 4.11
Zafgen 0.2 $468k 142k 3.31
Pronai Therapeutics 0.1 $238k 131k 1.82